Publications
Found 9 results
Filters: Author is Matagne, André [Clear All Filters]
"The unexpected structure of the designed protein Octarellin V.1 forms a challenge for protein structure prediction tools.",
J Struct Biol, vol. 195, issue 1, pp. 19-30, 2016 Jul.
"A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.",
J Phys Chem B, vol. 117, issue 42, pp. 13245-58, 2013 Oct 24.
"Three factors that modulate the activity of class D β-lactamases and interfere with the post-translational carboxylation of Lys70.",
Biochem J, vol. 432, issue 3, pp. 495-504, 2010 Dec 15.
"The zinc center influences the redox and thermodynamic properties of Escherichia coli thioredoxin 2.",
J Mol Biol, vol. 386, issue 1, pp. 60-71, 2009 Feb 13.
"Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.",
Biochemistry, vol. 47, issue 42, pp. 11041-54, 2008 Oct 21.
"Identification of a universal VHH framework to graft non-canonical antigen-binding loops of camel single-domain antibodies.",
J Mol Biol, vol. 352, issue 3, pp. 597-607, 2005 Sep 23.
"Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.",
J Mol Biol, vol. 346, issue 3, pp. 773-88, 2005 Feb 25.
"A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.",
Nature, vol. 424, issue 6950, pp. 783-8, 2003 Aug 14.
"Single-domain antibody fragments with high conformational stability.",
Protein Sci, vol. 11, issue 3, pp. 500-15, 2002 Mar.